trending Market Intelligence /marketintelligence/en/news-insights/trending/Ul6B19jnUuTWFajmP1BGXA2 content esgSubNav
In This List

Eloxx Pharmaceuticals names CEO

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Eloxx Pharmaceuticals names CEO

Eloxx Pharmaceuticals Inc. appointed Robert Ward as its chairman and CEO.

Ward succeeds founder and current CEO Silvia Noiman and outgoing Chairman of the Board Robert Heft.

He most recently served as the president and CEO of Radius Health Inc.

Ward brings to Eloxx more than 30 years of experience as a global biopharmaceutical industry leader with experience across the full spectrum of drug development, commercialization and strategic business development transactions, the company said in a statement.